Investment firm GI Partners closes Clinical Ink acquisition
Private equity investment firm GI Partners has announced the completion of the acquisition of global clinical trial technology firm Clinical…
Private equity investment firm GI Partners has announced the completion of the acquisition of global clinical trial technology firm Clinical…
Private equity investment firm GI Partners has announced that it will acquire a minority interest in global clinical trial technology Clinical Ink. Clinical Ink, which captures and integrates electronic data…
The International Vaccine Institute (IVI) and Seoul National University (SNU) Hospital have partnered to conduct a Phase I/II clinical trial of Inovio Pharmaceuticals' Covid-19 vaccine, INO-4800, in South Korea. This…
Virtual clinical trials firm Science 37 has partnered with AiCure, an artificial intelligence (AI) and advanced data analytics firm, for virtual trials technology. The partners will initially leverage a virtual…
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline. The Feinstein Institutes for Medical Research at Northwell Health in…
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline. A researcher at the University of British Columbia in Canada…
PCI Pharma Services has acquired Canadian company Bellwyck Pharma Services to bring its clinical trial services to Canada and continental Europe. Financial terms of the acquisition have not been disclosed.…